Skip to main content
Top

Tobacco Induced Diseases

Issue 1/2005

Content (7 Articles)

Open Access Editorial

Editorial

J Elliott Scott

Open Access Letter to the editor

Of Skiers, Smokers And Amelioration Of The World

David Bernhard

Open Access Letter to the editor

Comment on Oral White Lesions Associated with Chewing Khat

Ali Aiman

Open Access Review

Cardiovascular Risk Behavior among Sedentary Female Smokers and Smoking Cessation Outcomes

Tellervo Korhonen, Taru Kinnunen, Zandra Quiles, Robert F. Leeman, Donna Medaglia Terwal, Arthur J. Garvey

Open Access Review

Factors Related to Cigarette Smoking Initiation and Use among College Students

Diane Von Ah, Sheryl Ebert, Anchalee Ngamvitroj, Najin Park, Duck-Hee Kang

Open Access Letter to the editor

Letter to the Editor

A Zavras, M Falagas

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine